Article
Oncology
Valeria Faccenda, Denis Panizza, Valerio Pisoni, Sara Trivellato, Martina Camilla Daniotti, Sofia Paola Bianchi, Elena De Ponti, Stefano Arcangeli
Summary: This study investigated the efficacy of linac-based SRS/fSRS treatments using the single-isocenter coplanar FFF-VMAT technique for single and multiple BM. Analysis of patient cases showed that for single BM patients, GTV D95% was rarely reduced by more than 5%, while reductions of PTV D95% greater than 1% only occurred in 11 cases (29%). For multiple BM patients, dose deficits of >5% and >1% were observed in 2 GTV (2%) and 34 PTV (37%), respectively.
Article
Oncology
Laure Kuntz, Clara Le Fevre, Delphine Jarnet, Audrey Keller, Philippe Meyer, Christophe Mazzara, Helene Cebula, Georges Noel, Delphine Antoni
Summary: This retrospective study analyzed the data of patients who received at least two courses of SRT between 2010 and 2020. The results showed that NDFS and OS after SRT were influenced by various factors, including the number of treatments, patient condition, salvage WBRT, and metastasis velocity.
Article
Oncology
F. Deodato, D. Pezzulla, S. Cilla, M. Ferro, R. Giannini, C. Romano, M. Boccardi, M. Buwenge, V. Valentini, A. G. Morganti, G. Macchia
Summary: This study reports the final results of a dose-escalation study of VMAT-SRS boost in patients with spine metastases. The study found that a 12 Gy dose of SRS boost after 25 Gy to the affected and adjacent vertebrae resulted in excellent local control and survival rates without significant toxicity.
Article
Oncology
Neal Andruska, William R. Kennedy, Liberty Bonestroo, Rebecca Anderson, Yi Huang, Clifford G. Robinson, Christopher Abraham, Christina Tsien, Nels Knutson, Keith M. Rich, Christopher Spencer, Jiayi Huang
Summary: This study identifies BrainV25 and BrainV30 as significant dosimetric predictors of symptomatic radiation necrosis (sRN) in brain metastases treated with 5-fraction stereotactic radiosurgery (5fSRS). Maintaining BrainV25Gy < 16 cm(3) and BrainV30Gy < 10 cm(3) may minimize the risk of sRN, especially in lesions without prior SRS treatment.
RADIOTHERAPY AND ONCOLOGY
(2021)
Article
Health Care Sciences & Services
Fabiana Gregucci, Ilaria Bonaparte, Alessia Surgo, Morena Caliandro, Roberta Carbonara, Maria Paola Ciliberti, Alberto Aga, Francesco Berloco, Marina De Masi, Christian De Pascali, Federica Fragnoli, Chiara Indellicati, Rosalinda Parabita, Giuseppe Sanfrancesco, Luciana Brana, Annarita Ciocia, Domenico Curci, Pietro Guida, Alba Fiorentino
Summary: The study tested the inter-fraction reproducibility and intrafraction stability of a dedicated immobilization solution for Brain Linac-based radiation therapy, showing that the solution is accurate and stable. Combining CBCT and SGRT data confirmed the adequacy of a 1 mm CTV-PTV margin for Linac-based SRT. The use of an open-face mask and SGRT may allow for the omission of radiological imaging for conventional RT.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Oncology
L. Kuntz, C. Le Fevre, D. Jarnet, A. Keller, P. Meyer, A. Thiery, H. Cebula, G. Noel, D. Antoni
Summary: Brain metastases are a major cause of intracranial malignant neoplasms in adults. Multiple factors can predict the prognosis of patients and help determine the treatment approach. This study reviewed the characteristics of patients treated with repeated stereotactic radiotherapy and found that it had minimal impact on the overall condition of patients and showed potential for long-term survival.
RADIATION ONCOLOGY
(2023)
Article
Oncology
Mateusz Jacek Spalek, Tomasz Mandat
Summary: Brain metastases are common in patients with breast cancer, with treatment options including surgery and radiotherapy. However, some patients may still experience intracranial progression despite local treatment. The choice of optimal treatment methods should take into consideration various factors such as patient performance status, cancer burden, toxicity, and previous therapies.
Article
Oncology
Angela Barillaro, Mara Caroprese, Laura Cella, Anna Viggiano, Francesca Buccelli, Chiara Daponte, Chiara Feoli, Caterina Oliviero, Stefania Clemente, Antonio Farella, Manuel Conson, Roberto Pacelli
Summary: Brain metastases are severe events in patients with solid tumors. Stereotactic radiation therapy is an effective treatment for brain metastases, but it may lead to radiation necrosis, which can impact patient's quality of life. Prompt recognition and treatment are necessary for managing radiation necrosis.
Article
Oncology
Naoyuki Kanayama, Toshiki Ikawa, Shingo Ohira, Takero Hirata, Masahiro Morimoto, Kazuhiko Ogawa, Teruki Teshima, Koji Konishi
Summary: This study demonstrates that a significant reduction in brain metastases volume at 6 months post-SRT can predict local control. The dose of 80% of the gross tumor volume (GTV) D80 in the LQ model: alpha/beta = 20 may be a predictive factor for volume reduction.
Article
Oncology
Tobias Hoelscher, Michael Baumann, Joerg Kotzerke, Klaus Zoephel, Frank Paulsen, Arndt-Christian Mueller, Daniel Zips, Lydia Koi, Christian Thomas, Steffen Lock, Mechthild Krause, Manfred Wirth, Fabian Lohaus
Summary: This study suggests that local ablative radiotherapy (aRT) is safe and effective for patients with oligometastatic prostate cancer, and one in five patients had no recurrent prostate-specific antigen after 3 years. This may be an option to avoid systemic therapy in selected patients.
EUROPEAN UROLOGY ONCOLOGY
(2022)
Review
Oncology
Giuseppe Minniti, Maximilian Niyazi, Nicolaus Andratschke, Matthias Guckenberger, Joshua D. Palmer, Helen A. Shih, Simon S. Lo, Scott Soltys, Ivana Russo, Paul D. Brown, Claus Belka
Summary: This review discusses the use of postoperative stereotactic radiosurgery (SRS) as an effective treatment option for resected brain metastases, providing superior local control compared to surgery alone and decreasing the risk of neurocognitive decline compared to whole brain radiotherapy (WBRT). Further investigation is needed to optimize dose prescription/fractionation, timing of treatment, and target delineation for improved outcomes.
RADIATION ONCOLOGY
(2021)
Review
Oncology
Eric J. J. Lehrer, Brianna M. M. Jones, Daniel R. R. Dickstein, Sheryl Green, Isabelle M. M. Germano, Joshua D. D. Palmer, Nadia Laack, Paul D. D. Brown, Vinai Gondi, Jeffrey S. S. Wefel, Jason P. P. Sheehan, Daniel M. M. Trifiletti
Summary: Brain metastases are common intracranial neoplasms, with WBRT showing good intracranial tumor control rates but lacking survival benefits and causing cognitive decline and quality of life issues. Strategies such as incorporating memantine and hippocampal avoidance, as well as using SRS, have shown improved outcomes in recent years.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Felix Ehret, Carolin Senger, Markus Kufeld, Christoph Fuerweger, Melina Kord, Alfred Haidenberger, Paul Windisch, Daniel Ruess, David Kaul, Maximilian Ruge, Christian Schichor, Joerg-Christian Tonn, Alexander Muacevic
Summary: Robotic radiosurgery (RRS) is a safe, time-saving, and effective treatment modality for intramedullary metastases, especially for patients with unresectable lesions. Many symptoms improve or remain stable after treatment, and most treated lesions are controlled until death. These findings can guide further palliative care for affected patients.
Article
Biochemistry & Molecular Biology
Catia Monteiro, Lauritz Miarka, Maria Perea-Garcia, Neibla Priego, Pedro Garcia-Gomez, Laura Alvaro-Espinosa, Ana de Pablos-Aragoneses, Natalia Yebra, Diana Retana, Patricia Baena, Coral Fustero-Torre, Osvaldo Grana-Castro, Kevin Troule, Eduardo Caleiras, Patricia Tezanos, Pablo Muela, Elisa Cintado, Jose Luis Trejo, Juan Manuel Sepulveda, Pedro Gonzalez-Leon, Luis Jimenez-Roldan, Luis Miguel Moreno, Olga Esteban, Angel Perez-Nunez, Aurelio Hernandez-Lain, Jose Mazarico Gallego, Irene Ferrer, Rocio Suarez, Eva M. Garrido-Martin, Luis Paz-Ares, Celine Dalmasso, Elizabeth Cohen-Jonathan Moyal, Aurore Siegfried, Aisling Hegarty, Stephen Keelan, Damir Vareslija, Leonie S. Young, Malte Mohme, Yvonne Goy, Harriet Wikman, Jose Fernandez-Alen, Guillermo Blasco, Lucia Alcazar, Clara Cabanuz, Sergei Grivennikov, Andrada Ianus, Noam Shemesh, Claudia C. Faria, Rebecca Lee, Paul Lorigan, Emilie Le Rhun, Michael Weller, Riccardo Soffietti, Luca Bertero, Umberto Ricardi, Joaquim Bosch-Barrera, Elia Sais, Eduard Teixidor, Alejandro Hernandez-Martinez, Alfonso Calvo, Javier Aristu, Santiago M. Martin, Alvaro Gonzalez, Omer Adler, Neta Erez, Manuel Valiente
Summary: This study identifies a molecular mechanism underlying resistance to whole-brain radiotherapy and suggests potential targets and biomarkers for personalized radiotherapy. The findings have important implications for improving the efficacy of treatment for patients with brain metastasis.
Article
Oncology
Pauline Roussille, Marie Auvray, Damien Vansteene, Thierry Lecomte, Eugenie Rigault, Marianne Maillet, Christophe Locher, Marie Dior, Vincent Hautefeuille, Pascal Artru, May Mabro, Yann Touchefeu, Lysiane Marthey, Valerie Moulin, Samy Louafi, Cedric Lecaille, Romain Chautard, Astrid Lievre, Aziz Zaanan, Jaafar Bennouna, Antoine Berger, Sheik Emambux, Violaine Randrian, David Tougeron
Summary: This study evaluated prognostic factors of brain metastases from colorectal cancer and found that ECOG performance status, number of brain metastases, and number of chemotherapy lines are the most relevant factors in the management of patients with this condition.
RADIOTHERAPY AND ONCOLOGY
(2021)
Article
Oncology
Niels Verburg, Thomas Koopman, Maqsood M. Yaqub, Otto S. Hoekstra, Adriaan A. Lammertsma, Frederik Barkhof, Petra J. W. Pouwels, Jaap C. Reijneveld, Jan J. Heimans, Annemarie J. M. Rozemuller, Anne M. E. Bruynzeel, Frank Lagerwaard, William P. Vandertop, Ronald Boellaard, Pieter Wesseling, Philip C. de Witt Hamer
Article
Oncology
Tobias Finazzi, Cornelis J. A. Haasbeek, Femke O. B. Spoelstra, Miguel A. Palacios, Marjan A. Admiraal, Anna M. E. Bruynzeel, Berend J. Slotman, Frank J. Lagerwaard, Suresh Senan
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(2020)
Article
Oncology
Tobias Finazzi, Miguel A. Palacios, Cornelis J. A. Haasbeek, Marjan A. Admiraal, Femke O. B. Spoelstra, Anna M. E. Bruynzeel, Berend J. Slotman, Frank J. Lagerwaard, Suresh Senan
RADIOTHERAPY AND ONCOLOGY
(2020)
Article
Oncology
Drew Moghanaki, Berend Slotman, Anand Swaminath, Benjamin Nelms, Brian Wang
PRACTICAL RADIATION ONCOLOGY
(2020)
Article
Oncology
Jaap van den Berg, Kitty C. M. Castricum, Michael H. Meel, Ruben S. A. Goedegebuure, Frank J. Lagerwaard, Ben J. Slotman, Esther Hulleman, Victor L. J. L. Thijssen
RADIOTHERAPY AND ONCOLOGY
(2020)
Article
Oncology
Berend J. Slotman, Yolande Lievens, Philip Poortmans, Valerie Cremades, Thomas Eichler, Daniel Victor Wakefield, Umberto Ricardi
RADIOTHERAPY AND ONCOLOGY
(2020)
Article
Oncology
Max Dahele, Jim P. Tol, Marije R. Vergeer, Femke Jansen, Birgit Lissenberg-Witte, C. Rene Leemans, Ben J. Slotman, Irma M. Verdonck-de Leeuw, Wilko F. A. R. Verbakel
RADIOTHERAPY AND ONCOLOGY
(2020)
Article
Oncology
Omar Bohoudi, Anna M. E. Bruynzeel, Shyama Tetar, Ben J. Slotman, Miguel A. Palacios, Frank J. Lagerwaard
Summary: The study found that dose parameters based on total accumulated delivered bladder dose were better at predicting acute urinary symptoms. Additionally, dose parameters from the first 3 of 5 fractions also showed good correlation and could potentially be used to optimize MRgRT for the remaining fractions.
RADIOTHERAPY AND ONCOLOGY
(2021)
Article
Oncology
I. F. Remmerts de Vries, Max Dahele, Hassan Mostafavi, Ben Slotman, Wilko Verbakel
Summary: The study evaluated the use of kV imaging for tumor tracking during lung SBRT treatment and found that 3D positional verification during single fraction lung SBRT is feasible but improvements are needed. The results showed that the treatment time with this method was fast, but there was a significant amount of time where the tumor position could not be determined.
RADIOTHERAPY AND ONCOLOGY
(2021)
Article
Oncology
Isabel F. Remmerts de Vries, Merle I. Ronden, Idris Bahce, Femke O. B. Spoelstra, Patricia F. De Haan, Cornelis J. A. Haasbeek, Birgit I. Lissenberg-Witte, Ben J. Slotman, Max Dahele, Wilko F. A. R. Verbakel
Summary: Concurrent chemoradiotherapy (cCRT) is the preferred treatment for patients with stage III NSCLC, however, concerns about treatment toxicity remain significant.
Article
Oncology
M. C. Tjong, A. Louie, A. K. Singh, G. Videtic, K. Stephans, N. Plumridge, S. Harden, B. J. Slotman, F. Alongi, M. Guckenberger, S. Siva
Summary: This overview provides a summary of the current evidence on the efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, compared with multi-fraction SABR regimens. A comprehensive literature search was conducted to identify relevant trials and cohort studies, and the review discusses the radiobiological, technical, and organ at risk considerations of single-fraction SABR for lung treatment.
Article
Oncology
Florien W. Boele, Patricia W. M. den Otter, Jaap C. Reijneveld, Philip C. de Witt Hamer, Hinke F. van Thuijl, Linda M. C. Lorenz, Pieter Wesseling, Frank J. Lagerwaard, Martin J. B. Taphoorn, Mathilde C. M. Kouwenhoven, Tom J. Snijders, Linda Douw, Martin Klein
Summary: HRQOL and NCF do not appear greatly impacted during long-term survivorship in LGG, but depressive symptoms and fatigue are persistent.
Article
Oncology
Miguel A. Palacios, Georgi Gerganov, Paul Cobussen, Shyama U. Tetar, Tobias Finazzi, Berend J. Slotman, Suresh Senan, Cornelis J. A. Haasbeek, Iwan Kawrakow
Summary: This study evaluated the accuracy of automatic tumor segmentation in MR-guided radiotherapy (MRgRT) by comparing it to manual delineations performed by experienced observers. The results showed a high level of agreement between automatic segmentation and manual delineation.
PHYSICS & IMAGING IN RADIATION ONCOLOGY
(2023)
Article
Oncology
Hilal Tekatli, Miguel A. Palacios, Famke L. Schneiders, Cornelis J. A. Haasbeek, Ben J. Slotman, Frank J. Lagerwaard, Suresh Senan
Summary: This study investigated the long-term clinical outcomes of MR-guided SF-SABR on a 0.35 T linac for lung tumors. The results showed that SF-SABR, using automatic beam gating during breath-holds, achieved good tumor control and low toxicity.
RADIOTHERAPY AND ONCOLOGY
(2023)
Article
Oncology
Shyama U. Tetar, Anna M. E. Bruynzeel, Lisa Verweij, Omar Bohoudi, Berend J. Slotman, Tezontl Rosario, Miguel A. Palacios, Frank J. Lagerwaard
Summary: The study showed that daily plan adaptation in magnetic resonance-guided radiotherapy for intermediate- and high-risk prostate cancer can achieve adequate treatment coverage, especially for seminal vesicles.
PHYSICS & IMAGING IN RADIATION ONCOLOGY
(2022)
Article
Oncology
Derek A. Mumaw, Allison J. Hazy, Aleksander Vayntraub, Thomas J. Quinn, Kamran Salari, John H. Chang, Noah Kalman, Sanford Katz, James Urbanic, Robert H. Press, Arpi Thukral, Henry Tsai, George E. Laramore, Jason Molitoris, Carlos Vargas, Samir H. Patel, Craig Stevens, Rohan L. Deraniyagala
Summary: This study evaluated contralateral recurrences in patients with oropharyngeal squamous cell carcinoma who received unilateral proton beam therapy. The results showed a favorable contralateral neck failure rate that was comparable to photon irradiation.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Kangpyo Kim, Dongryul Oh, Jae Myoung Noh, Yang Won Min, Hong Kwan Kim, Yong Chan Ahn
Summary: This study suggests that hypofractionated radiation therapy alone is a feasible option for early stage esophageal squamous cell carcinoma patients. Particularly, in patients with tumor length < 3 cm, this treatment scheme shows favorable local control rates with low incidence of esophageal toxicities.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Lin Chen, Jing Li, Kunpeng Li, Jiang Hu, Qingjie Li, Chenglong Huang, Gaoyuan Wang, Na Liu, Linglong Tang
Summary: This study analyzed the probability of hearing impairment after radiotherapy for nasopharyngeal carcinoma and developed a predictive model, providing dose limitation suggestions to improve patients' quality of life.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Yiwei Yang, Jianxin Wang, Feng Gao, Zhen Liu, Tangzhi Dai, Haowen Zhang, Hongyu Zhu, Tingting Wang, Dexin Xiao, Kui Zhou, Zheng Zhou, Dai Wu, Xiaobo Du, Sen Bai
Summary: This paper provides a comprehensive description of the current status of PARTER, which is the first experimental FLASH platform utilizing megavoltage X-rays. It showcases the reliable performance and stability of the dosimeters and monitors used in PARTER, as well as the satisfactory dose distribution and characteristics of the FLASH X-rays. The platform effectively meets the requirements of preclinical research on megavoltage X-ray FLASH and undergoes continuous upgrades.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Maria Thor, Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase, Saad Nadeem, Ellen D. Yorke, Jamie Chaft, Abraham J. Wu, Michael Offin, Charles B. Simone Ii, Isabel Preeshagul, Daphna Y. Gelblum, Daniel Gomez, Joseph O. Deasy, Andreas Rimner
Summary: The purpose of this study was to identify predictors of disease progression in early-stage non-small cell lung cancer (NSCLC) patients after receiving definitive stereotactic body radiation therapy (SBRT). The results showed that tumor diameter and SUVmax were the most frequently reported features associated with progression/survival, and a re-fitted model including these two features had the best performance.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Yong-Qiao He, Tong-Min Wang, Da-Wei Yang, Wen-Qiong Xue, Chang-Mi Deng, Dan-Hua Li, Wen-Li Zhang, Ying Liao, Ruo-Wen Xiao, Lu-Ting Luo, Hua Diao, Xia-Ting Tong, Yan-Xia Wu, Xue-Yin Chen, Jiang-Bo Zhang, Ting Zhou, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Shao-Dan Zhang, Ye-Zhu Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Wei-Hua Jia
Summary: In this study, researchers aimed to establish a predictive model for radiation-induced brain injury (RBI) in nasopharyngeal carcinoma (NPC) patients by incorporating clinical factors and newly developed genetic variants. They conducted a large-scale retrospective study and a genome-wide association study to develop a polygenic risk score (PRS) for RBI risk prediction. The results showed that the PRS, combined with clinical factors, improved the accuracy of RBI risk stratification and suggested personalized radiotherapy.
RADIOTHERAPY AND ONCOLOGY
(2024)
Review
Oncology
Xiaoyong Xiang, Zhe Ji, Jing Jin
Summary: A review of studies suggests that brachytherapy as a salvage therapy for recurrent glioblastoma shows acceptable safety and good post-treatment clinical efficacy for selected patients.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
M. Berbee, C. T. Muijs, F. E. M. Voncken, L. Wee, M. Sosef, B. van Etten, J. W. van Sandick, F. A. R. M. Warmerdam, J. J. de Haan, E. Oldehinkel, J. M. van Dieren, L. Boersma, J. A. Langendijk, A. van der Schaaf, J. B. Reitsma, E. Schuit
Summary: This study externally validated a model for predicting 2-year total mortality in lung cancer patients in esophageal cancer patients. The intercept and/or slope of the original model needed adjustment to achieve good performance in esophageal cancer patients.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Dominique Reijtenbagh, Jeremy Godart, Joan Penninkhof, Sandra Quint, Andras Zolnay, Jan-Willem Mens, Mischa Hoogeman
Summary: This study compared the performance of the current PotD strategy with non-adaptive and fully online-adaptive techniques in the treatment of cervical cancer patients. The findings show that the PotD protocol is effective in improving normal tissue sparing compared to no adaptation, while fully online-adaptive approaches can further reduce target volume but come with a more complex workflow.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Albrecht Weiss, Steffen Loeck, Ting Xu, Zhongxing Liao, Aswin L. Hoffmann, Esther G. C. Troost
Summary: Traditional models for predicting radiation pneumonitis may not be applicable to non-small cell lung cancer patients treated with passively-scattered proton therapy. The use of effective alpha/beta parameter can predict the occurrence of radiation pneumonitis in these patients.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Z. A. R. Gouw, J. Jeong, A. Rimner, N. Y. Lee, A. Jackson, A. Fu, J-j. Sonke, J. O. Deasy
Summary: This study investigates the effectiveness of non-uniform fractionation schedules in radiotherapy for early-stage non-small cell lung cancer. Through modeling, optimized schedules are proposed to minimize local failures and toxicity risk. The results suggest that non-standard primer shot fractionation can reduce hypoxia-induced radioresistance and improve treatment outcomes.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Sara Ronchi, Alessandro Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni
Summary: This study evaluates the efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma patients. The results show that CIRT is safe and effective in treating the local region, and immunotherapy after relapse can improve overall survival. However, further prospective trials are needed to assess the role of targeted/immune- systemic therapy in this disease.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Dominik Wawrzuta, Justyna Klejdysz, Marzanna Chojnacka
Summary: This study analyzed articles about radiation oncology published in The New York Times since its inception in 1851, and identified changes in media sentiment and prevalent themes related to radiotherapy. The findings suggest an increasing negative sentiment in media coverage towards radiotherapy, with a shift towards reporting treatment errors, toxicity, and ineffectiveness.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Elaine Limkin, Pierre Blanchard, Benjamin Lacas, Jean Bourhis, Mahesh Parmar, Lisa Licitra, Quynh-Thu Le, Sue S. Yom, Catherine Fortpied, Johannes Langendijk, Jan B. Vermorken, Jacques Bernier, Jens Overgaard, Jonathan Harris, Jean-Pierre Pignon, Anne Auperin
Summary: This study investigated the impact of season of radiotherapy on the outcomes of head and neck squamous cell cancer patients. The results showed that the season of radiotherapy did not have any significant effect on patient outcomes.
RADIOTHERAPY AND ONCOLOGY
(2024)
Article
Oncology
Fabio L. Cury, Gustavo A. Viani, Andre G. Gouveia, Camila V. S. Freire, Gabriel de A. Grisi, Fabio Y. Moraes
Summary: In limb-sparing treatment of soft tissue sarcoma patients, a 5-day course of preoperative radiotherapy results in high local control and favorable R0 margins, with acceptable complication rates, particularly for patients receiving higher biological equivalent doses.
RADIOTHERAPY AND ONCOLOGY
(2024)
